Pharmacogenomic Data: FDA Voluntary and Required Submission Guidance
- 1 July 2004
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 5 (5) , 503-505
- https://doi.org/10.1517/14622416.5.5.503
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pharmacogenomic Data Submissions to the FDA: Clinical Case StudiesPharmacogenomics, 2004
- Pharmacogenomic Data Submissions to the FDA: Non-Clinical Case StudiesPharmacogenomics, 2004
- Pharmacogenomic Data Submissions to the FDA: Clinical Pharmacology Case StudiesPharmacogenomics, 2004
- Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) ProposalPharmacogenomics, 2004